TransMedics: How a MedTech Pioneer is Redefining Organ Transplantation
Reading Time: 4 minutes
Founder-driven growth story: From the cooler to a high-tech platform with a scalable business model. Stock after price doubling: Long-term exciting, short-term with a bullish chart and momentum toward new highs. The investment story of TransMedics does not begin on Wall Street, but in an operating room of the 1990s. Young heart surgeon Waleed Hassanein stands before a donor heart, which lies on ice in a simple cooler—and wonders if it can be that one of the most complex therapies of modern medicine depends on camping equipment. This frustration...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

